MMNFQ (MedMen Enterprises) EBITDA Margin %: -79.72% (As of Mar. 2023)


What is MedMen Enterprises EBITDA Margin %?

MedMen Enterprises MMNFQ -90.00% EBITDA Margin % is -79.72% as of Mar. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MedMen Enterprises's EBITDA for the three months ended in Mar. 2023 was $-21.7 Mil. MedMen Enterprises's Revenue for the three months ended in Mar. 2023 was $27.2 Mil. Therefore, MedMen Enterprises's EBITDA margin for the quarter that ended in Mar. 2023 was -79.72%.

MedMen Enterprises  (OTCPK:MMNFQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

MedMen Enterprises EBITDA Margin % Related Terms

MedMen Enterprises EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises EBITDA Margin % Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -222.66 -182.34 -269.22 -31.21 -75.80

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.63 -287.23 -8.18 2.39 -79.72

MMNFQ vs ZTS, VTRS, NBIX: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's EBITDA Margin % falls into.


MedMen Enterprises EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MedMen Enterprises's EBITDA Margin % for the fiscal year that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-106.731/140.812
=-75.80 %

MedMen Enterprises's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-21.705/27.225
=-79.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -79.72% mean?
MedMen Enterprises (MMNFQ) has a EBITDA Margin % of -79.72% as of Mar. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' EBITDA Margin % too high?
MedMen Enterprises' current EBITDA Margin % is -79.72%.
How does MedMen Enterprises' EBITDA Margin % compare to ZTS and VTRS?
MedMen Enterprises' EBITDA Margin % of -79.72% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MedMen Enterprises and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedMen Enterprises's current EBITDA Margin % is -79.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current EBITDA Margin % of -79.72%. The current EBITDA Margin % is -79.72%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current EBITDA Margin % is -79.72% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.